Edition:
United Kingdom

Corcept Therapeutics Inc (CORT.OQ)

CORT.OQ on NASDAQ Stock Exchange Capital Market

16.48USD
23 Feb 2018
Change (% chg)

$0.39 (+2.42%)
Prev Close
$16.09
Open
$17.24
Day's High
$18.33
Day's Low
$16.08
Volume
1,007,524
Avg. Vol
635,833
52-wk High
$25.92
52-wk Low
$8.39

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 53.28 0.772
Sep '17 42.76 0.109
Jun '17 35.56 0.103
Mar '17 27.60 0.036
FY 2016 Dec '16 23.81 0.039
Sep '16 21.73 0.022
Jun '16 19.72 0.008
Mar '16 16.06 -0.000
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 58.90 62.20 55.00 37.22
Quarter Ending Jun-18 3 67.37 69.30 64.82 39.38
Year Ending Dec-18 4 265.25 290.00 219.95 171.35
Year Ending Dec-19 3 332.26 357.79 300.00 180.82
Earnings (per share)
Quarter Ending Mar-18 3 0.20 0.22 0.16 0.08
Quarter Ending Jun-18 3 0.24 0.26 0.22 0.09
Year Ending Dec-18 4 0.92 1.06 0.71 0.41
Year Ending Dec-19 2 1.33 1.64 1.01 0.50
LT Growth Rate (%) 1 71.00 71.00 71.00 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 101.94 31.10 32.90
P/E High - Last 5 Yrs. 103.58 40.92 45.97
P/E Low - Last 5 Yrs. 103.58 23.79 24.37
Beta 2.07 0.90 0.89
Price to Sales (TTM) 21.25 3.98 5.77
Price to Book (MRQ) 34.91 4.84 5.41
Price to Tangible Book (MRQ) 34.92 5.66 6.98
Price to Cash Flow (TTM) 95.16 23.02 23.42
% Owned Institutions 63.80 1.25 2.22

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) 0.00 45.86 43.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 80.28 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago 69.80 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago 1,113.81 16.65 19.66
EPS (TTM) vs TTM 1 Yr. Ago 1,631.63 -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate 50.65 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.83 2.11 2.18
Current Ratio (MRQ) 3.99 2.89 2.97
LT Debt to Equity (MRQ) 0.00 9.91 12.22
Total Debt to Equity (MRQ) 6.91 13.93 16.52
Interest Coverage (TTM) 1.52 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 97.56 55.11 54.70
Gross Margin - 5 Yr. Avg. 97.36 52.40 52.42
EBITD Margin (TTM) 23.62 -- --
EBITD - 5 Yr. Avg -57.13 18.51 10.86
Operating Margin (TTM) 23.57 14.36 4.64
Operating Margin - 5 Yr. Avg. -57.41 14.42 6.26
Pre-Tax Margin (TTM) 22.44 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -66.18 14.73 6.60
Net Profit Margin (TTM) 22.28 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -66.18 11.07 2.91
Effective Tax Rate (TTM) 0.73 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,055,291 948,744,532 855,673,508
Net Income/Employee (TTM) 235,116 111,622,899 100,656,226
Receivable Turnover (TTM) 11.56 5.62 5.78
Inventory Turnover (TTM) 1.01 2.58 3.35
Asset Turnover (TTM) 1.52 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 33.78 11.45 10.98
Return on Assets - 5 Yr. Avg. -37.52 12.98 12.37
Return on Investment (TTM) 50.69 14.91 14.43
Return on Investment - 5 Yr. Avg. -49.15 16.98 16.18
Return on Equity (TTM) 52.76 16.41 16.13
Return on Equity - 5 Yr. Avg. -83.61 18.08 17.47
  1 Year 3 Year 5 Year
Sales % 61.72 98.76 --
EPS (TTM) % 216.91 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Corcept Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 18.02 13.95 99 25
13 Week 69.33 61.08 99 35
26 Week 91.27 76.73 99 30
52 Week 210.99 163.59 99 12
YTD 180.58 146.40 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.94%
# of Holders: 274
Total Shares Held: 91,231,304
3 Mo. Net Change: 15,032,703
# New Positions: 55
# Closed Positions: 45
# Increased Positions: 150
# Reduced Positions: 115
# Net Buyers: 35
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.